Explore the Global Cardiac Biomarker Diagnostic Test Kits Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Cardiac Biomarker Diagnostic Test Kits Market

Key Insight

Brain natriuretic peptide test kits will lead cardiac biomarker diagnostic test kits sales through 2036 with 25.0% share of the product type segment in 2026, driven by clinical adoption and regulatory compliance requirements. The market was valued at USD 2.10 billion in 2025 and is expected to be worth USD 3.48 billion by 2036.

May 25, 2026

Anurag Sharma

239 Pages

Cite this Report

Cardiac Biomarker Diagnostic Test Kits Market

https://www.futuremarketinsights.com/reports/cardiac-bio-marker-diagnostic-test-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Bio-Rad Laboratories
F. Hoffmann-La Roche Ag
PerkinElmer
QuidelOrtho Corporation
Randox Laboratories Ltd
Hoffmann-La Roche
Siemens
Siemens Healthineers AG

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Cardiac Biomarker Diagnostic Test Kits Market

Key Players

Similar Industry Reports